The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib.
| Image |  |
|---|---|
| Description | scientific article published on April 2006 |
| Author/s |
author: Cornelius Miething |
| Publication date | April 1, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |